Advanced Investigational Drug Supply Strategy and Demand Planning in Complex Clinical Trial Designs
Wednesday, June 12th, 2024
2pm JST
Improving drug supply management and increasing efficiency
As we know, there has been a recent trend toward the
use of complex designs in clinical trials such as Cohort Management, Dose Modification,
especially in oncology, and the implementation of multiple types of drugs and
doses has become the norm.
On the other hand, the costs and burdens related to
investigational drugs are also increasing year by year. Therefore, regardless
of the number of drug types, it is generally important for Sponsor to reduce
the wastage of investigational drug consumption in addition to producing only
the amount of investigational drugs that are really needed, and for Site to
receive the appropriate quantities of the investigational drugs in the proper
timing and maintain sufficient site stocks without overstock in case of Dose Modification,
also from a patient-centric perspective.
While IRT utilization is
essential to address these issues, further optimization of investigational drug
supply can be achieved through advanced strategic planning that goes beyond the
conventional theories of IRT supply strategy and advanced forecasting that makes
full utilization of system integration.
In this webinar, we will introduce how to make a highly accurate drug supply regardless of the design complexity and how to utilize the drug consumption data for optimizing drug production.
- Advanced Drug Supply Strategy by Suvoda IRT
- Optimization of Drug Supply Projection
- Advanced Optimization of Drug Supply Strategy and Drug Supply Strategy and Drug Production through System Integration
Meet the Speakers

Tomoyuki Yamashita
Director, Services Delivery
at Suvoda Japan
Register now to watch on-demand!
By completing this form you agree Suvoda and Citeline may contact you directly about industry news, products, services and events that may be of interest. This is subject to Suvoda's privacy policy and Citeline’s privacy policy